PresentationGood day, and thank you for standing by. Welcome to the YUVIWEL FDA-Approved Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Chad Fugure, Vice President, Investor Relations. Please go ahead.Chad FugureVice President of Investor Relations Thank you, operator, and thank you, everyone, for joining our conference call this morning. I'm Chad Fugure, Vice President, Investor Relations of ...

Ascendis Pharma (NasdaqGS:ASND) FDA announcement March 02, 2026 08:00 AM ET Company ParticipantsAimee Shu - EVP and Chief Medical OfficerAlex Thompson - Managing DirectorChad Fugere - VP of Investor RelationsGavin Clark-Gartner - Director of Biotechnology Equity ResearchHeidi Jacobson - Equity Research AssociateJan Mikkelsen - President and CEOJay Wu - EVPMaxwell Schorr - Senior VPSimone Nasroodin - Biotech Equity Research AssociateTazeen Ahmad - Managing DirectorYaron Werber - Managing DirectorYun Zhong - ...